Contemporary OB/GYN week in review: covid vaccines, hypertension, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: covid vaccines, hypertension, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, November 27 - Friday, December 1, 2023), and click each link to read and watch anything you may have missed.
1.) Inactivated COVID-19 vaccines in pregnancy: No impact on neonatal outcome, study finds
A comprehensive cohort study explored the impact of inactivated COVID-19 vaccines administered within 3 months before conception, revealing reassuring findings that neonatal outcomes, including preterm birth and NICU admission, remain unaffected.
Click here for the full article.
2.) Impact of racial discrimination on hypertension risk in highly-educated Black women
Explore the pivotal role of educational attainment in shaping the complex link between racial and ethnic discrimination and hypertension risk in Black women.
Click here for the full article.
3.) Link between reproductive life span and postmenopausal muscle mass
A recent study in Menopause, the journal of The Menopause Society, suggests that a longer reproductive life span and later age at menopause may be associated with a reduced risk of low handgrip strength in postmenopausal women.
Click here for the full article.
4.) Navigating reproductive health: Insights on menstrual cycles and autoimmune diseases
Researchers from the Hospital for Special Surgery (HSS) present new data on how autoimmune diseases impact pregnant women, particularly in fertility.
Click here for the full article.
5.) A closer look at women's concerns on breast density in clinician discussions
A study found variations in discussions about breast density based on race and ethnicity, leading researchers to urge enhanced cultural competency and shared decision-making to bridge critical gaps in breast density conversations.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
Prenatal SSRI or SNRI discontinuation not linked to adverse psychiatric outcomes
October 8th 2024In a recent study, similar rates of adverse psychiatric-related outcomes were reported among patients with discontinuation of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors vs those without discontinuation.
Read More
